Edward Christopher Dee: Cancer incidence and mortality estimates in 2022 in southeast Asia
Edward Christopher Dee, Resident Physician in Radiation Oncology at Memorial Sloan Kettering Cancer Center, shared a post on X about a recent paper he co-authored with colleagues published in The Lancet Oncology:
“I am honored to share our work, “Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis,” published in The Lancet Group.
Southeast Asia, today home to over 700 million people, is immensely diverse. Many of the region’s people live in the extremes of social and political determinants of health. Therefore, we were motivated to examine cancer in the region, to guide health system strengthening.
We collaborated with IARC – International Agency for Research on Cancer / World Health Organization to present the most updated and high quality estimates available for the 11 ASEAN Foundation countries.
The data are not without their limitations, underscoring the need for further strengthening of cancer registration in many countries.
- By 2050, cancer cases will nearly double to 2.03 million annually, and deaths are projected to increase by 94.7%.
- Breast cancer is the most common cancer in women. However, survival disparities persist across the region.
- Lung cancer is the leading cause of death in men, due in large part to smoking and pollution.
- Infection-related cancers including cancers of the liver and cervix are common in many countries.
- Colorectal cancer is on the rise.
We underscore the need to improve access to care, including mitigating costs, to dedicate increased resources to cancer control, to develop and implement national cancer control plans, and to promote research, policy, and clinical collaboration among countries in Southeast Asia.
Doing so will require global collaboration and knowledge exchange. We hope this paper represents a microcosm of that exchange.
This work is the combined effort of colleagues, mentors, and friends from over a dozen countries. Their collective work has spanned academia, clinical care, and cancer policy. Their dedication to our patients continues to be an inspiration and a beacon.
This effort is dedicated to our patients, their families, and their caregivers, and to all who care for people with cancer in Southeast Asia and
throughout the world.”
Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis
Authors: Edward Christopher Dee, Mathieu Laversanne, Nirmala Bhoo-Pathy, Frances Dominique V Ho, Erin Jay G Feliciano, Michelle Ann B Eala, Frederic Ivan L Ting, Ophira Ginsburg, Fabio Ynoe Moraes, Bishal Gyawali, Scarlett Lin Gomez, Kenrick Ng, James Fan Wu, Urvish Jain, Bhav Jain, Rod Carlo Columbres, Tomohiro Matsuda, Suleeporn Sangrajrang, Evlina Suzanna Sinuraya, Tung Duc Bui, Wenqiang Wei, Young-Joo Won, Ling Li Foo, Mei Chuan Annie Ling, Les Mery, Isabelle Soerjomataram and Freddie Bray.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023